101 related articles for article (PubMed ID: 2415736)
1. Somatostatin, substance P and [Lys]-vasopressin interfere with the binding of [3H][D-Ala2, Met5]enkephalinamide to rat brain membranes.
Maruyama M
Jpn J Pharmacol; 1985 Aug; 38(4):445-7. PubMed ID: 2415736
[TBL] [Abstract][Full Text] [Related]
2. Binding and metabolism studies with [3H](D-Ala2,Leu5)enkephalinamide and [3H](D-Ala2,Pro5)enkephalinamide: evidence for a selective interaction of (D-Ala2,Pro5)enkephalinamide with mu-receptors.
Audigier Y; Mazarguil H; Roy J; Morgat JL; Cros J
Eur J Pharmacol; 1981 Sep; 74(4):273-8. PubMed ID: 6271558
[TBL] [Abstract][Full Text] [Related]
3. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
Wong-Dusting HK; Rand MJ
Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
[TBL] [Abstract][Full Text] [Related]
4. Binding characteristics of [3H]opioid ligands to active opioid binding sites solubilized from rat brain membranes by glycodeoxycholate and NaCl: the recovery of binding activity by dilution.
Maruyama M; Sugino H; Akita K; Hatanaka H
Brain Res; 1987 Jan; 401(1):14-22. PubMed ID: 2880641
[TBL] [Abstract][Full Text] [Related]
5. Substance P stimulates the release of Met5-enkephalin-Arg6-Phe7 and Met5-enkephalin from rat spinal cord.
Tang J; Chou J; Yang HY; Costa E
Neuropharmacology; 1983 Sep; 22(9):1147-50. PubMed ID: 6195549
[TBL] [Abstract][Full Text] [Related]
6. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
Wolozin BL; Pasternak GW
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
[TBL] [Abstract][Full Text] [Related]
7. Radioiodinated [D-Ala2, Met5] enkephalin. Preparation, purification by high performance liquid chromatography and binding characteristics.
Yeung CW
Int J Pept Protein Res; 1984 Dec; 24(6):636-44. PubMed ID: 6099338
[TBL] [Abstract][Full Text] [Related]
8. Photoaffinity labeling of opioid receptor of rat brain membranes with 125I(D-Ala2, p-N3-Phe4-Met5)enkephalin.
Yeung CW
Arch Biochem Biophys; 1987 Apr; 254(1):81-91. PubMed ID: 3034163
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of D-Ala2 analogues of enkephalins on substance P-induced analgesia in rodents.
Naranjo JR; Del Rio J
Eur J Pharmacol; 1982 Aug; 82(3-4):213-6. PubMed ID: 6182008
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide.
Lembeck F; Donnerer J; Barthó L
Eur J Pharmacol; 1982 Nov; 85(2):171-6. PubMed ID: 6185352
[TBL] [Abstract][Full Text] [Related]
11. Effects of putative calmodulin antagonists on the binding of [3H]opioid ligands to rat brain membranes: possible involvement of the change in the membrane fluidity.
Maruyama M; Akita K
Jpn J Pharmacol; 1986 Oct; 42(2):159-67. PubMed ID: 3025488
[TBL] [Abstract][Full Text] [Related]
12. Irreversible labelling of the opioid receptors by a melphalan-substituted [Met5]enkephalin-Arg-Phe derivative.
Sartania N; Szatmári I; Orosz G; Rónai AZ; Medzihradszky K; Borsodi A; Benyhe S
Eur J Pharmacol; 1999 Jun; 373(2-3):241-9. PubMed ID: 10414445
[TBL] [Abstract][Full Text] [Related]
13. Peptides influence retinal ganglion cells.
Dick E; Miller RF
Neurosci Lett; 1981 Oct; 26(2):131-5. PubMed ID: 6170917
[TBL] [Abstract][Full Text] [Related]
14. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
15. Distribution of radioactivity in the spinal cord after intracerebroventricular and intravenous injection of radiolabeled opioid peptides in mice.
Ohlsson AE; Fu TC; Jones D; Martin BR; Dewey WL
J Pharmacol Exp Ther; 1982 May; 221(2):362-7. PubMed ID: 6281413
[TBL] [Abstract][Full Text] [Related]
16. Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide.
Childers SR
J Pharmacol Exp Ther; 1984 Sep; 230(3):684-91. PubMed ID: 6088761
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta-adrenergic blocking agents on specific binding of [3H]D-Ala2-Met5-enkephalinamide and [3H]naloxone.
Takayama H; Ogawa N; Asanuma M; Hirata H; Ogura T; Ota Z
Acta Med Okayama; 1991 Oct; 45(5):295-9. PubMed ID: 1684486
[TBL] [Abstract][Full Text] [Related]
18. pH selectivity of N-ethylmaleimide reactions with opiate receptor complexes in rat brain membranes.
Childers SR; Jackson JL
J Neurochem; 1984 Oct; 43(4):1163-70. PubMed ID: 6088695
[TBL] [Abstract][Full Text] [Related]
19. Photoreactive enkephalin analogue: [D-Ala2, p-N3-Phe4-Met5]-enkephalin. Synthesis, purification by high performance liquid chromatography and characterization.
Yeung CW
Int J Pept Protein Res; 1985 Jul; 26(1):63-9. PubMed ID: 2997057
[TBL] [Abstract][Full Text] [Related]
20. CNS involvement in the antisecretory action of [Met5]enkephalinamide on the rat intestine.
Brown DR; Miller RJ
Eur J Pharmacol; 1983 Jun; 90(4):441-4. PubMed ID: 6884432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
